Cocrystal Pharma Inc (COCP)
1.63
+0.13
(+8.67%)
USD |
NASDAQ |
Mar 28, 11:27
Cocrystal Pharma Cash from Operations (TTM): -16.23M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -16.23M |
June 30, 2023 | -22.46M |
March 31, 2023 | -20.64M |
December 31, 2022 | -21.44M |
September 30, 2022 | -19.46M |
June 30, 2022 | -15.96M |
March 31, 2022 | -14.86M |
December 31, 2021 | -12.72M |
September 30, 2021 | -12.18M |
June 30, 2021 | -9.836M |
March 31, 2021 | -9.412M |
December 31, 2020 | -9.83M |
September 30, 2020 | -8.679M |
June 30, 2020 | -6.941M |
March 31, 2020 | -5.769M |
December 31, 2019 | -1.563M |
September 30, 2019 | -2.303M |
June 30, 2019 | -3.129M |
March 31, 2019 | -4.194M |
December 31, 2018 | -8.29M |
September 30, 2018 | -7.90M |
June 30, 2018 | -7.937M |
March 31, 2018 | -6.929M |
December 31, 2017 | -6.903M |
September 30, 2017 | -7.624M |
Date | Value |
---|---|
June 30, 2017 | -8.584M |
March 31, 2017 | -12.66M |
December 31, 2016 | -14.66M |
September 30, 2016 | -15.39M |
June 30, 2016 | -15.44M |
March 31, 2016 | -12.80M |
December 31, 2015 | -10.32M |
September 30, 2015 | -9.032M |
June 30, 2015 | -6.984M |
March 31, 2015 | -5.791M |
December 31, 2014 | -6.012M |
September 30, 2014 | -5.065M |
June 30, 2014 | -4.874M |
March 31, 2014 | -4.514M |
December 31, 2013 | -3.686M |
September 30, 2013 | -2.830M |
June 30, 2013 | -1.481M |
March 31, 2013 | -0.6052M |
December 31, 2012 | -1.589M |
September 30, 2012 | -2.017M |
June 30, 2012 | -1.608M |
March 31, 2012 | -1.894M |
December 31, 2011 | -0.421M |
September 30, 2011 | 0.0839M |
June 30, 2011 | -0.6392M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-22.46M
Minimum
Jun 2023
-1.563M
Maximum
Dec 2019
-11.45M
Average
-9.836M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -5.026M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -17.82M |
Ampio Pharmaceuticals Inc | -10.55M |